NCT07787052Recruiting
R-GASTIM- Study of Gastric Cancer Operable
R-GASTIM - Clinicobiological Cohort of Gastric Cancers
Source: ClinicalTrials.gov · Last updated 26 Aug 2026
Brief summary (registry, in English)
Clinicobiological cohort of gastric cancers operated in our institution.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 30 Sept 2024
- Start date
- 30 Sept 2024
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Centre Leon Berard
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT07787052
What you commit to
- Study type: Observational
- Planned participants: 60
- From 30 Sept 2024 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient refusal to participate to this clinicobiological cohort
Who the study is looking for
- Adult patients with histologically proven non-metastatic resectable gastric and gastroesophageal junction adenocarcinoma, Stage IB to III be treated with standard neoadjuvant chemotherapy
- Knwon response to neoadjuvant chemotherapy as per TRG criteria
- Surgery of primary tumor done at Centre Léon Bérard. Availability of archival FFPE tumor block from initial diagnosis with at least 20% of tumor cells and collected lymp nodes
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Leon Berard Coordinator of this site? Confirm its status | Lyon | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.